Abstract:Severe fever with thrombocytopenia syndrome (SFTS) is a rapidly progressive infectious disease triggered by a novel bunyavirus (SFTSV). Despite the critical role of host lipid metabolism in viral infections, research on dyslipidemia in SFTS remains limited. This retrospective study included 433 SFTS patients, who were stratified into survival group (n = 365) and death group (n = 68) and who were treated at the Shandong Public Health Clinical Center from September 2021 to December 2023. Additionally, 96 healthy controls with matching baseline characteristics were included from Shandong Provincial Hospital. Cross-sectional analysis based on admission data and longitudinal analysis over time were employed to survey the correlation between serum lipid profiles and mortality in SFTS patients. SFTS patients exhibited elevated triglyceride (TG) levels and reduced total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levels compared to healthy individuals. Cross-sectional analysis demonstrated that lower LDL-C and apolipoprotein-B (ApoB) levels were related to elevated mortality risk in SFTS patients. Longitudinal analysis demonstrated that LDL-C and ApoB levels remained consistently lower in the death group, while TG levels gradually declined, and HDL-C levels gradually increased as the disease progressed. SFTS patients exhibit significant dyslipidemia compared to healthy individuals. Lower LDL-C and ApoB levels may independently influence mortality in SFTS patients. Elevated TG and reduced HDL-C levels may associate with disease progression. In recent years, research into Severe Fever with Thrombocytopenia Syndrome (SFTS) has intensified; however, there remains a paucity of studies addressing SFTS through the lens of serum lipid metabolism. It is well-documented that lipid metabolism plays a pivotal role in viral infections, as evidenced by numerous investigations across various viral diseases. Crucially, examining SFTS from the perspective of lipid metabolism not only enhances our understanding of viral pathogenesis but may also yield valuable insights for therapeutic interventions. This study provides a thorough examination of the serum lipid profiles in SFTS patients from a clinical perspective. Our findings first establish that SFTS patients exhibit significant lipid metabolic dysregulation compared to healthy controls. Furthermore, both cross-sectional and longitudinal analyses reveal a notable correlation between low-density lipoprotein cholesterol (LDL-C) and apolipoprotein-B (ApoB) levels and the prognosis of SFTS patients. Finally, our research opens new avenues for future investigations into SFTS by emphasizing the importance of lipid metabolism.

Lower serum LDL-C levels are associated with poor prognosis in severe fever with thrombocytopenia syndrome: a single-center retrospective cohort study

Dyslipidemia in severe fever with thrombocytopenia syndrome patients: A retrospective cohort study

Correlations between clinical features and death in patients with severe fever with thrombocytopenia syndrome.

Serum lipidome reveals lipid metabolic dysregulation in severe fever with thrombocytopenia syndrome

Association of Liver Function and Prognosis in Patients with Severe Fever with Thrombocytopenia Syndrome

Clinical Progress and Risk Factors for Death from Severe Fever with Thrombocytopenia Syndrome: A Multihospital Retrospective Investigation in Anhui, China.

CD4 T cell loss and Th2 and Th17 bias are associated with the severity of severe fever with thrombocytopenia syndrome (SFTS).

Clinical Characteristics and Immune Status of Patients with Severe Fever with Thrombocytopenia Syndrome.

Decreased Myeloid Dendritic Cells Indicate a Poor Prognosis in Patients with Severe Fever with Thrombocytopenia Syndrome.

Differential short-term and long-term metabolic and cytokine responses to infection of severe fever with thrombocytopenia syndrome virus

Analysis of Severe Fever with Thrombocytopenia Syndrome in Critical Ill Patients in Central China.

Prognostic Value of Serum Ferritin for Patients with Severe Fever with Thrombocytopenia Syndrome: A Single-Center Retrospective Cohort Study

Concurrent Measurement of Dynamic Changes in Viral Load, Serum Enzymes, T Cell Subsets, and Cytokines in Patients with Severe Fever with Thrombocytopenia Syndrome

Decreased Monocyte Subsets and TLR4-mediated Functions in Patients with Acute Severe Fever with Thrombocytopenia Syndrome (SFTS).

Clinical features of severe fever with thrombocytopenia syndrome and analysis of risk factors for mortality

Analysis of Early Warning Indicators of Death in Patients with Severe Fever with Thrombocytopenia Syndrome

The associations between fasting blood glucose levels and mortality of SFTS in patients

Downregulation of Interferon-β and Inhibition of TLR3 Expression are associated with Fatal Outcome of Severe Fever with Thrombocytopenia Syndrome

Risk Factors for Mortality in Severe Fever with Thrombocytopenia Syndrome Patients with Central Nervous System Complications

Clinical Progress and Risk Factors for Death in Severe Fever with Thrombocytopenia Syndrome Patients.

Prediction of prognosis in patients with severe fever with thrombocytopenia syndrome